Galderma, Switzerland's discreet Botox empire
The dermatology company's market capitalization has doubled since its initial public offering in 2024. Despite recurring scandals, botulinum toxin injections are expected to rake in $13 billion this year.
Read the full story at Le Monde in English ↗
ImpactNotable 40/100
Why it mattersRule-based estimate: event keywords (+6); trust 9/10.
RegionsFrance
Published1 h ago (Fri, 02 Oct 2026 02:49:37 GMT)
RetrievedFri, 02 Oct 2026 03:00:28 GMT via rss
ClassifiedFri, 02 Oct 2026 03:00:38 GMT by heuristic